Why has the biotechnology industry failed to perform up to expectations? This book attempts to answer this question by providing a critique of the industry. It reveals the causes of biotech's problems and offers an analysis on how the industry works. It also provides prescriptions for companies, seeking ways to improve the industry's performance.

Most books on the biotechnology industry focus on scientific and technological challenges, ignoring the entrepreneurial and managerial complexities faced bio-entrepreneurs. The Business Models for Life Science Firms aims to fill this gap by offering managers in this rapid growth industry the tools needed to design and implement an effective business model customized for the unique needs of research intensive organizations. Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and strategy: focus, exploring the different activities carried out by the organization; locus, evaluating where organizational activities are centered; and modus, testing the execution of the organization’s activities. The business model thus defines the unique way in which a company delivers on its promise to its customers. The theory and applications adopt a global approach, offering business cases from a variety of biotech companies around the world.

The extraordinary account of the Cuban people’s struggle for survival in a post-Soviet world In the aftermath of the fall of the Soviet Union, Cuba faced the start of a crisis that decimated its economy. Helen Yaffe examines the astonishing developments that took place during and beyond this period. Drawing on archival research and interviews with Cuban leaders, thinkers, and activists, this book tells for the first time the remarkable story of how Cuba survived while the rest of the Soviet bloc crumbled. Yaffe shows how Cuba has been gradually introducing select market reforms. While the government claims that these are necessary to sustain its socialist system, many others believe they herald a return to capitalism. Examining key domestic initiatives including the creation of one of the world’s leading biotechnological industries, its energy revolution, and medical internationalism alongside recent economic reforms, Yaffe shows why the revolution will continue post-Castro. This is a fresh, compelling account of Cuba’s socialist revolution and the challenges it faces today.

The book contains a selection of papers on business clusters in its multiple perspectives. It has evolved from the research symposium organized by the The Society for Global Business and Economic Development (SGBED), an international group of academicians, at Dubai during January 2009. It begins with an introduction to the concept of clusters, and then examines their link to a host of strategic issues, such as their nexus to competitive advantage, their performance vis-à-vis their competitors who are not similarly agglomerated, and the challenges in measuring the performance of clusters. Regional economic clusters have serious policy implications. Governments, local as well as national, have used clusters as the unit for investment and infrastructure upgrading policies. It focuses on the normative aspects as well as practices and provides pointers on how public policies can help the development and growth of regional economic clusters. With numerous examples and cases from a host countries such as Dubai, Mexico, Spain and Karnataka (India), the book is a must read for all students of business strategy.

The VTAC eGuide is the Victorian Tertiary Admissions Centre’s annual guide to application for tertiary study, scholarships and special consideration in Victoria, Australia. The eGuide contains course listings and selection criteria for over 1,700 courses at 62 institutions including universities, TAFE institutes and independent tertiary colleges.

With contributions from an international array of experts, this book explains why biotechnology companies in different countries are concentrated in a small number of locations and what accounts for their success.

The first book to provide a simple and practical means of valuing biotech companies The book begins with a short history of the biotechnology industry; this is important as although it is about 30 years old, the first company went public only in 1996, so it is possible to plot the course of investment waves and dips It examines the European industry and its evolvement, and draws parallels between the similarities and differences between that and the US Looks at the various companies which make up the biotech industry (therapeutic; life sciences; and the medical technology company) and gives tools for the investor to properly evaluate them Praise for Biotechnology Valuation "Keegan states that the valuation of Biotech companies is as much an art as a science. This brief but comprehensive review of the skills and knowledge required, not of just the financial market and sentiment, but also of the technical attributes of a company and the drug development and regulatory hurdles that must be overcome, highlights the importance of the breadth of understanding required. Biotech investing is not for the timid, but it can bring substantial returns. Keegan's book, punctuated with his personal experience and opinions, is a good place to start." —Chris Blackwell, Chief Executive, Vectura Group plc "A user-friendly, yet thorough discussion of a notoriously difficult topic. Dr Keegan's book is a fine resource for both business types and academicians." —Steve Winokur, Managing Director, CanaccordAdams "A highly readable and comprehensive explanation of the technical and commercial parameters that influence biotechnology companies at all stages of development, providing clear context for selection from the toolkit of valuation methodologies the author recommends to assess company and product performance, or ascribe value." —Dr L.M. Allan, Director, Bioscience Enterprise Programme, University of Cambridge "A fabulous approach to a difficult topic." —Deirdre Y. Gillespie, MD, President & CEO, La Jolla Pharmaceutical Company

Methods, Processes, and Tools for Collaboration "The time has come to fundamentally rethink how we handle the building of knowledge in biomedical sciences today. This book describes how the computational sciences have transformed into being a key knowledge broker, able to integrate and operate across divergent data types." Bryn Williams-Jones, Associate Research Fellow, Pfizer The pharmaceutical industry utilizes an extended network of partner organizations in order to discover and develop new drugs, however there is currently little guidance for managing information and resources across collaborations. Featuring contributions from the leading experts in a range of industries, Collaborative Computational Technologies for Biomedical Research provides information that will help organizations make critical decisions about managing partnerships, including: Serving as a user manual for collaborations Tackling real problems from both human collaborative and data and informatics perspectives Providing case histories of biomedical collaborations and technology-specific chapters that balance technological depth with accessibility for the non-specialist reader A must-read for anyone working in the pharmaceuticals industry or academia, this book marks a major step towards widespread collaboration facilitated by computational technologies.

Innovation is central to the dynamics and success of organizations and society in the modern world, the process famously referred to by Schumpeter as 'gales of creative destruction'. This ambitious and wide ranging book makes the case for a new approach to the study of innovation. It is the editors' conviction that this approach must accomplish several objectives: it must recognise that innovation encompasses changes in organizations and society, as well as products and processes; it must be genuinely interdisciplinary and include contributes from economics, sociology, management and political science; It must be international, to reflect both different patterns or systems of innovation, and different research traditions; and it must reflect the fundamental changes taking place in science, research and knowledge creation at all levels. To this end they have gathered together a distinguished group of economists, sociologists, political scientists, and organization, innovation and institutional theorists to both assess current research on innovation, and to set out a new research agenda. This has been achieved through careful planning and development of the project, and also through the ensuing structure of the book which looks in turn at Product and Process Innovation (perhaps the best established focus of existing research on innovation), Scientific Research (assessing the changing character of basic research and science policy); Knowledge Dynamics in Context (encompassing organizational learning in all its aspects); and Institutional Change (an analysis of the institutional context that can shape, enable and constrain innovation). This carefully integrated and wide ranging book will be an ideal reference point for academics and researchers across the Social Sciences interested in all dimensions of innovation - be they in the field of Management Studies, Economics, Organization Studies, Sociology, Political Science and Science and Technology Studies.

Alfred D. Chandler, Jr. was, by general consensus, the pre-eminent business historian of the twentieth century. Through a prodigious body of work, Chandler made the study of the evolution of business enterprise integral to the study of the evolution of economy and society. His work combined detailed historical investigations with grand sociological syntheses. As a result, Chandler's study of the modern business enterprise invited social scientists and business academics as well as historians to contribute to our understanding of a central institution of our time. Chandler revealed how managerial activity was central to the functioning of successful industrial corporations, and hence to the performance of the economy as a whole. This book gathers together contributions from management scholars fundamentally influenced by the work of Chandler to discuss management innovation, the ways in which people who exercise strategic control over the allocation of resources put in place organizational structures that can enable an enterprise to prosper and grow. The volume offers a range of perspectives to examine the challenges that corporate management encounters.